1-(3-Fluorophenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 1g

Notoginsenoside R1>98.0%(HPLC)10mg

Methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetate, 97%, 1g

4-Bromo-3-methoxybenzonitrile, 98.0%, 100g

1-(4-Methoxy-phenyl)-ethylamine, 95.0%, 100g

(S)-3-Hydroxy-4-(trimethylammonio)butanoate, 98%, 250mg

tert-Butyl 2-((5-(tosyloxy)pentyl)oxy)acetate, 98%, 100mg

2-(azetidin-3-yl)ethan-1-ol hydrochloride, 97.0%, 1g

5-Bromo-2-thiophenesulfonamide>97.0%(GC)(T)25g

5-(4-PHENYL-5-(TRIFLUOROMETHYL)THIOPHEN-2-YL)-3-(3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOLE, 95%, 25mg

2-(2-CHLORO-4-MORPHOLINOTHIENO[3,2-D]PYRIMIDIN-6-YL)PROPAN-2-OL, 95.0%, 2g

Methyl 1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate, 95.0%, 5g

2-Iodobenzonitrile>98.0%(GC)25g